BioInvent International Management
Management criteria checks 3/4
BioInvent International's CEO is Martin Welschof, appointed in Sep 2018, has a tenure of 5.67 years. total yearly compensation is SEK5.17M, comprised of 55.5% salary and 44.5% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth €48.15K. The average tenure of the management team and the board of directors is 4.5 years and 6.3 years respectively.
Key information
Martin Welschof
Chief executive officer
kr5.2m
Total compensation
| CEO salary percentage | 55.5% |
| CEO tenure | 5.7yrs |
| CEO ownership | 0.03% |
| Management average tenure | 4.5yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -kr335m |
| Dec 31 2023 | kr5m | kr3m | -kr330m |
| Sep 30 2023 | n/a | n/a | -kr311m |
| Jun 30 2023 | n/a | n/a | -kr304m |
| Mar 31 2023 | n/a | n/a | -kr48m |
| Dec 31 2022 | kr5m | kr3m | -kr43m |
| Sep 30 2022 | n/a | n/a | -kr43m |
| Jun 30 2022 | n/a | n/a | -kr42m |
| Mar 31 2022 | n/a | n/a | -kr266m |
| Dec 31 2021 | kr5m | kr3m | -kr278m |
| Sep 30 2021 | n/a | n/a | -kr171m |
| Jun 30 2021 | n/a | n/a | -kr141m |
| Mar 31 2021 | n/a | n/a | -kr123m |
| Dec 31 2020 | kr5m | kr3m | -kr76m |
| Sep 30 2020 | n/a | n/a | -kr146m |
| Jun 30 2020 | n/a | n/a | -kr150m |
| Mar 31 2020 | n/a | n/a | -kr144m |
| Dec 31 2019 | kr4m | kr2m | -kr139m |
| Sep 30 2019 | n/a | n/a | -kr130m |
| Jun 30 2019 | n/a | n/a | -kr116m |
| Mar 31 2019 | n/a | n/a | -kr126m |
| Dec 31 2018 | kr3m | kr800k | -kr123m |
Compensation vs Market: Martin's total compensation ($USD476.77K) is below average for companies of similar size in the German market ($USD713.28K).
Compensation vs Earnings: Martin's compensation has increased whilst the company is unprofitable.
CEO
Martin Welschof (62 yo)
5.7yrs
Tenure
kr5,167,000
Compensation
Dr. Martin Welschof, Ph D had been the Chief Executive Officer of Opsona Therapeutics Limited since February 2012. Dr. Welschof has been Chief Executive Officer at BioInvent Intl AB (publ) since 2018.He i...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 5.7yrs | kr5.17m | 0.034% SEK 48.2k | |
| Chief Financial Officer | 8.3yrs | no data | 0.012% SEK 17.2k | |
| Chief Operating Officer | 2.3yrs | no data | no data | |
| Senior Vice President of Technical Operations | 7.7yrs | no data | 0.034% SEK 47.9k | |
| Chief Scientific Officer | no data | kr2.35m | 0.035% SEK 49.6k | |
| Senior Director of Investor Relations | 3.3yrs | no data | no data | |
| Chief Medical Officer | 7.3yrs | no data | 0.0046% SEK 6.5k | |
| Head of Preclinical Research | no data | no data | no data | |
| Chief Business Officer | 1.9yrs | no data | 0.035% SEK 49.2k | |
| Senior Vice President of Regulatory Affairs | less than a year | no data | no data |
4.5yrs
Average Tenure
58yo
Average Age
Experienced Management: BIX0's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 6.3yrs | kr595.00k | 0.10% SEK 141.9k | |
| Independent Chairman of the Board | 6.3yrs | kr782.00k | 0.051% SEK 72.1k | |
| Independent Director | 3.8yrs | kr510.00k | no data | |
| Independent Director | 3.1yrs | kr475.00k | no data | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Employee Representative Director | no data | no data | 0.0014% SEK 2.0k | |
| Director | 1.1yrs | kr475.00k | 0.027% SEK 38.7k | |
| Independent Director | 4yrs | kr520.00k | 0.044% SEK 62.3k | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
6.3yrs
Average Tenure
64yo
Average Age
Experienced Board: BIX0's board of directors are considered experienced (6.3 years average tenure).